Sharmin Baig

Sharmin Baig

Auto-generated profile, based on publicly available information

Sharmin Baig

Affiliation Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2023 in Eurosurveillance
Verified
Journal Article
Open access
TJThor Bech Johannesen
Thor Bech Johannesen
CMCharlotte Munkstrup
Charlotte Munkstrup
SESofie Edslev
Sofie Edslev
SBSharmin Baig
Sharmin Baig
SNStine Nielsen
Stine Nielsen
MSMarc Stegger
Marc Stegger
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.

7 September 2023 in Eurosurveillance
Verified
Journal Article
Open access
MRMorten Rasmussen
Morten Rasmussen
FMFrederik Trier Møller
Frederik Trier Møller
VGVithiagaran Gunalan
Vithiagaran Gunalan
SBSharmin Baig
Sharmin Baig
MBMarc Bennedbæk
Marc Bennedbæk
PJPikka Jokelainen
Pikka Jokelainen
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.

22 February 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MSMarc Stegger
Marc Stegger
SESofie Edslev
Sofie Edslev
RSRaphael Sieber
Raphael Sieber
AIAnna Cäcilia Ingham
Anna Cäcilia Ingham
KNKim Lee Ng
Kim Lee Ng
MRMorten Rasmussen
Morten Rasmussen
The newly found Omicron SARS-CoV-2 variant of concern has rapidly spread worldwide. Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. The variant has recently been divided into four subvariants with substantial genomic differences, in particular between Omicron BA.1 and BA.2. With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases has been observed, raising the question of whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection. To investigate this, we selected a subset of samples from more than 1,8 million cases of infections in the period from November 22, 2021, until February 11, 2022. Here, individuals with two positive samples, more than 20 and less than 60 days apart, were selected. From a total of 187 reinfection cases, we identified 47 instances of BA.2 reinfections shortly after a BA.1 infection, mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death. In conclusion, we provide evidence that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare.

26 August 2020 in mSphere
Verified
Journal Article
Open access
PDF file
SBSharmin Baig
Sharmin Baig
ALAnders Rhod Larsen
Anders Rhod Larsen
PSPatricia Martins Simoes
Patricia Martins Simoes
FLFrédéric Laurent
Frédéric Laurent
TJThor Bech Johannesen
Thor Bech Johannesen
MSMarc Stegger
Marc Stegger
Understanding the evolution of CA-MRSA is important in light of the increasing importance of this reservoir in the dissemination of MRSA. Here, we highlight the story of the CA-MRSA CC152 lineage using whole-genome sequencing on an international collection of CC152. We show that the evolution of this lineage is novel and that antibiotic usage may have the potential to select for the phage-encoded Panton-Valentine leukocidin. The diversity of the strains correlated highly to geography, with higher level of resistance observed among the European MRSA isolates. The mobility of the SCC mec element is mandatory for the emergence of novel MRSA lineages, and we show here distinct acquisitions, one of which is linked to the successful clone found throughout Europe today.

1 January 2019 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
STStaffan Tevell
Staffan Tevell
SBSharmin Baig
Sharmin Baig
ÅNÅsa Nilsdotter-Augustinsson
Åsa Nilsdotter-Augustinsson
MSMarc Stegger
Marc Stegger
BSBo Söderquist
Bo Söderquist
In current diagnostic criteria for implant-associated bone- and joint infections, phenotypically identical low-virulence bacteria in two intraoperative cultures are usually required. Using whole-genome sequencing, we have further characterized three phenotypically different Staphylococcus capitis isolated from one prosthetic joint infection, highlighting the challenges in defining microbiological criteria for low-virulence prosthetic joint infections.

16 October 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KEKirsten Ellegaard
Kirsten Ellegaard
VGVithiagaran Gunalan
Vithiagaran Gunalan
RSRaphael Sieber
Raphael Sieber
SBSharmin Jamshid Baig
Sharmin Jamshid Baig
NLNicolai Balle Larsen
Nicolai Balle Larsen
MSMarc Stegger
Marc Stegger
Protocols and pipelines for SARS-CoV-2 genome sequencing were rapidly established when the COVID-19 outbreak was declared a pandemic. The most widely used approach for sequencing SARS-CoV-2 includes targeted enrichment by PCR, followed by shotgun sequencing and reference-based genome assembly. As the continued surveillance of SARS-CoV-2 worldwide is transitioning towards a lower level of intensity, it is timely to re-visit the sequencing protocols and pipelines established during the acute phase of the pandemic. In the current study, we have investigated the impact of primer scheme and reference genome choice by sequencing samples with multiple primer schemes (Artic V3, V4.1 and V5.3.2) and re-processing reads with multiple reference genomes. We have also analysed the temporal development in ambiguous base calls during the emergence of the BA.2.86.x variant. We found that the primers used for targeted enrichment can result in recurrent ambiguous base calls, which can accumulate rapidly in response to the emergence of a new variant. We also found examples of consistent base calling errors, associated with PCR artifacts and amplicon drop-out. Similarly, misalignments and partially mapped reads on the reference genome resulted in ambiguous base calls, as well as defining mutations being omitted from the assembly. These findings highlight some key limitations of using targeted enrichment by PCR and reference-based genome assembly for sequencing SARS-CoV-2, and the importance of continuously monitoring and updating primer schemes and bioinformatic pipelines.